Prostate Cancer VL

How to Best Optimize Patient Care - Interview with Edward Schaeffer

Details
(Length of Discussion: 10 min) Edward (Ted) Schaeffer, MD, Ph.D. and Alicia Morgans, MD share a dynamic discussion on the risk strategy that may be employed for high-risk prostate cancer patients including oligometastatic disease. They share observations such as an increase in patient volume in their clinics of men with rising PSAs, high grade and locally advanced disease. In discussing the best w...

Use of Conservative Management for Low-Risk Prostate Cancer - Interview with Stacy Loeb

Details
(Length of Discussion: 7 min) Stacy Loeb, MD, and Alicia Morgans, MD discuss conservative management, active surveillance, and management trends over time for low-risk prostate cancer in the Veterans Affairs Integrated Health Care System over the past decade. Biographies: Stacy Loeb, MD, is an Assistant Professor of Urology and Population Health at New York University (NYU), specializing in prosta...

Long-Term Outcomes of Active Surveillance for Prostate Cancer - Interview with Sigrid Carlsson

Details
(Length of Conversation: 7 min) Sigrid Carlsson, MD talks with Alicia Morgans, MD about long-term outcomes of active surveillance for prostate cancer, a 17-year experience with active surveillance at the Memorial Sloan Kettering Cancer Center. A study which Carlsson was a co-author on and was presented at the most recent American Urological Association meeting (AUA2018). This was a retrospective a...

Personalization of Therapy to Optimize Outcomes for Men with Prostate Cancer - Interview with Felix Feng

Details
(Length of Conversation: 10 min) Felix Feng, MD talks with Alicia Morgans, MD, MPH on identifying subsets of patients with prostate cancer that are most responsive to certain therapies so the physician can better individualize treatment options for patients. Topics they discuss include predictive biomarkers, hormone therapy, early initiation of hormone therapy for patients treated with surgery up...

Geriatric Assessment of Men with Prostate Cancer - Alicia Morgans

Details
(Length of Presentation: 16 min) Alicia Morgans, MD presents a Geriatric Assessment of Men with Prostate Cancer. She outlines the importance of geriatric considerations in prostate cancer and implementing it into the clinical management of patients. She details initial treatment decision making including staging the aging and estimation of remaining life expectancy. She also discusses consideratio...

Radical Prostatectomy for Patients with Oligometastatic Prostate Cancer - Robert Hamilton

Details
(Length of Discussion: 18 min) Dr. Robert Hamilton, a Staff Urologic Oncologist from Princess Margaret Cancer Centre in Toronto, Canada discusses radical prostatectomy for patients with oligometastatic prostate cancer. He overviews the clinical and biological rationale for radical prostatectomy in the oligometastases setting and highlights the role of novel imaging. He reviews four major PET trace...

Discussion on Prostate Rectum Spacing in Radiation Therapy - Lawrence Karsh

Details
(Length of Discussion: 15 min) Dr. Lawrence I. Karsh discusses SpaceOAR Hydrogel and it's use as a prostate-rectum spacer for treating prostate cancer with radiation therapy. He presents a study he took part in which aimed to evaluate the safety of the prostate-rectum spacer application technique as well as the following: the implant quality and resulting rectal dose reduction, acute and long term...

Discussion on SPARTAN: A Study of Apalutamide in Men with Non-Metastatic Castration-resistant Prostate Cancer - Thomas Keane

Details
(Length of Discussion 17 min) Dr. Thomas Keane reviews recent groundbreaking data presented at the 2018 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium focusing on the much awaiting results of the SPARTAN trial. Dr. Keane started by highlighting the SPARTAN Trial presentation by Dr. Eric Small. A Study of Apalutamide (ARN-509) in Men with Non-Metastatic Castration-r...

GayBiProstate Study: Expanding Quality of Life and Understanding Sexual Function Post Treatment - Bernard Lee

Details
(Length of Discussion: 12 min) Dr. Bernard Lee shares the background and details of the GayBiProstate Study with Dr. Alicia Morgans. He explains the GayBiProstate study was developed for a patient population which is historically under studied when it comes to quality of life. The study focuses on sexual function of gay and bisexual patients ages 18-75 with a history of prostate cancer who have re...

Maelstrom: The Metabolic Syndrome in Men - Jeannette Potts

Details
(Length of Discussion: 23 min) Dr. Jeannette Potts, a private practice physician specializing in holistic care for men suffering from chronic pelvic pain, presents the topic “Maelstrom”, and the metabolic syndrome in men. Dr. Potts speaks to the incidence of metabolic syndrome and its growth in the USA and abroad. Many unhealthy habits and abnormal health parameters are associated with MetS, which...